Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Larocca

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumorsF O Ranelletti, R Ricci, L M Larocca, et al.
British Journal of Cancer|December 1, 1990
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsG Scambia, F O Ranelletti, P B Panici, et al.
Cell Death and Differentiation|May 24, 2008
Mesenchymal differentiation of glioblastoma stem cellsL Ricci-Vitiani, R Pallini, L M Larocca, et al.
Haematologica|April 6, 1999
Acute hemorrhagic leukoencephalitis in patients with acute myeloid leukemia in hematologic complete remissionL Pagano, L M Larocca, M L Vaccario, et al.
European Journal of Haematology|July 1, 1996
Severe anaemia as first sign of metastatic alveolar rhabdomyosarcomaA Di Mario, S Sica, G d'Onofrio, et al.
Biomedicines|December 23, 2023
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid ResultFrancesco Pierconti, E D Rossi, V Fiorentino, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2016
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worseA Orlandi, M A Calegari, M Martini, et al.
Transplantation Proceedings|August 19, 2007
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient seriesA W Avolio, S Agnes, R Barbarino, et al.
British Journal of Cancer|November 24, 2012
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patientsM Basso, A Strippoli, A Orlandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomasS Hohaus, M Giachelia, G Massini, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumorsF O Ranelletti, R Ricci, L M Larocca, et al.
British Journal of Cancer|December 1, 1990
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsG Scambia, F O Ranelletti, P B Panici, et al.
Cell Death and Differentiation|May 24, 2008
Mesenchymal differentiation of glioblastoma stem cellsL Ricci-Vitiani, R Pallini, L M Larocca, et al.
Haematologica|April 6, 1999
Acute hemorrhagic leukoencephalitis in patients with acute myeloid leukemia in hematologic complete remissionL Pagano, L M Larocca, M L Vaccario, et al.
European Journal of Haematology|July 1, 1996
Severe anaemia as first sign of metastatic alveolar rhabdomyosarcomaA Di Mario, S Sica, G d'Onofrio, et al.
Biomedicines|December 23, 2023
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid ResultFrancesco Pierconti, E D Rossi, V Fiorentino, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2016
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worseA Orlandi, M A Calegari, M Martini, et al.
Transplantation Proceedings|August 19, 2007
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient seriesA W Avolio, S Agnes, R Barbarino, et al.
British Journal of Cancer|November 24, 2012
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patientsM Basso, A Strippoli, A Orlandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomasS Hohaus, M Giachelia, G Massini, et al.
Pageof 13